Skip to main content

Articles

Page 2 of 18

  1. The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available treatments than 20 years ago, treatment access and high ...

    Authors: A. John Rush, Robert E. Gore-Langton, Gavin Bart, Katharine A. Bradley, Cynthia I. Campbell, James McKay, David W. Oslin, Andrew J. Saxon, T. John Winhusen, Li-Tzy Wu, Landhing M. Moran and Betty Tai
    Citation: Addiction Science & Clinical Practice 2024 19:14
    Content type: Meeting Report Published on:

  2. People who inject drugs (PWID) are at increased risk of HIV acquisition and often encounter barriers to accessing healthcare services. Uganda has high HIV prevalence among PWID and lacks integrated pre-exposur...

    Authors: Brenda Kamusiime, Kristin Beima-Sofie, Nok Chhun, Alisaati Nalumansi, Grace Kakoola Nalukwago, Vicent Kasiita, Chris Collins Twesige, Ritah Kansiime, Timothy R. Muwonge, Peter Kyambadde, Herbert Kadama, Peter Mudiope, Sara Glick, Barrot Lambdin, Andrew Mujugira and Renee Heffron
    Citation: Addiction Science & Clinical Practice 2024 19:13
    Content type: Research Published on:

  3. Research is lacking on predictors of outcome for the treatment of alcohol use disorder (AUD) with a goal of controlled drinking (CD). The aim of the study was to investigate one-year outcomes of an RCT, invest...

    Authors: Stina Ingesson-Hammarberg, Nitya Jayaram-Lindström and Anders Hammarberg
    Citation: Addiction Science & Clinical Practice 2024 19:12
    Content type: Research Published on:

  4. Non-profit hospitals in the U.S. are required by the 2010 Patient Protection and Affordable Care Act (ACA) to conduct a community health needs assessment (CHNA) every three years and to formulate an implementa...

    Authors: Cory E. Cronin, Luke Kubacki, Lauren Donovan, Neeraj Puro, Dakota Lavinder, Kristin Schuller and Berkeley Franz
    Citation: Addiction Science & Clinical Practice 2024 19:11
    Content type: Research Published on:

  5. Implementation of medications for opioid use disorder (MOUD) in jails varies by facility and across states. Organizational climate, including staff attitudes toward change and exposure to education, can influe...

    Authors: Pryce S. Michener, Elizabeth A. Evans, Warren J. Ferguson and Peter D. Friedmann
    Citation: Addiction Science & Clinical Practice 2024 19:10
    Content type: Research Published on:

  6. This study aimed to synthetize the evidence on the effectiveness of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviors among people who inject drugs (PWID) t...

    Authors: Fernanda S. Tonin, Filipa Alves da Costa and Fernando Fernandez-Llimos
    Citation: Addiction Science & Clinical Practice 2024 19:9
    Content type: Review Published on:

  8. The opioid epidemic has resulted in expanded substance use treatment services and strained the clinical workforce serving people with opioid use disorder. Focusing on evidence-based counseling practices like m...

    Authors: K. Michelle Peavy, Angela Klipsch, Christina S. Soma, Brian Pace, Zac E. Imel, Michael J. Tanana, Sean Soth, Esther Ricardo-Bulis and David C. Atkins
    Citation: Addiction Science & Clinical Practice 2024 19:8
    Content type: Research Published on:

  9. Buprenorphine is a highly effective medication for opioid use disorder that is underused by health care professionals (HCPs). Medications for opioid use disorder (MOUD) misinformation may be an important barri...

    Authors: Berkeley Franz, Lindsay Y. Dhanani, O. Trent Hall, Daniel L. Brook, Cheyenne Fenstemaker, Janet E. Simon and William C. Miller
    Citation: Addiction Science & Clinical Practice 2024 19:7
    Content type: Research Published on:

  10. Nicotine replacement therapy (NRT) and short messaging service (SMS)-based tobacco cessation interventions have demonstrated effectiveness in reducing tobacco use in many populations, but evidence is needed on...

    Authors: Heather Wipfli, Jim Arinaitwe, Fastone Goma, Lynn Atuyambe, David Guwatudde, Masauso Moses Phiri, Elizeus Rutebemberwa, Fred Wabwire-Mangen, Richard Zulu, Cosmas Zyambo, Kyra Guy, Ronald Kusolo, Musawa Mukupa, Ezekiel Musasizi and Joan S. Tucker
    Citation: Addiction Science & Clinical Practice 2024 19:6
    Content type: Study Protocol Published on:

  11. People who use drugs (PWUD) face disproportionately high rates of hospitalizations and patient-initiated discharge (leaving against medical advice), explained by a combination of stigma, withdrawal, judgment, ...

    Authors: William Rioux, Kyle Kilby, Stephanie Jones, Pamela Joshi, Stephanie Vandenberg and S. Monty Ghosh
    Citation: Addiction Science & Clinical Practice 2024 19:4
    Content type: Research Published on:

  12. Unhealthy alcohol use (UAU) is particularly dangerous for people with chronic liver disease. Liver clinics may be an important setting in which to provide effective alcohol-related care by integrating evidence...

    Authors: Elena M. Soyer, Madeline C. Frost, Olivia V. Fletcher, George N. Ioannou, Judith I. Tsui, E. Jennifer Edelman, Bryan J. Weiner, Rachel L. Bachrach, Jessica A. Chen and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2024 19:3
    Content type: Research Published on:

  13. Alcohol, tobacco and illicit drug use during pregnancy can cause significant harm to women and their developing fetuses. Despite recommendations for abstinence during pregnancy, some women continue to use, mak...

    Authors: Matthew W. R. Stevens, Megan Cooper, Lynette Cusack, Robert L. Ali and Annette L. Briley
    Citation: Addiction Science & Clinical Practice 2024 19:2
    Content type: Study Protocol Published on:

  14. Approximately 70–80% of people experiencing homelessness in the United States use tobacco. Smoking cessation programs specifically for this population have been found to be less effective for African American ...

    Authors: Alexandria Jones-Patten, Sanghyuk S. Shin, Adeline Nyamathi and Dawn Bounds
    Citation: Addiction Science & Clinical Practice 2024 19:1
    Content type: Research Published on:

  15. Authors: Filipa Krolo-Wicovsky, Sophie Baumann, Anika Tiede, Gallus Bischof, Ulrich John, Beate Gaertner and Jennis Freyer-Adam
    Citation: Addiction Science & Clinical Practice 2023 18:74
    Content type: Correction Published on:

    The original article was published in Addiction Science & Clinical Practice 2023 18:68

  16. Injectable opioid agonist treatment (iOAT) has proven to be a safe and effective treatment option for severe opioid use disorder (OUD). Yet, iOAT is often isolated from other health and social services. To ali...

    Authors: Sophia Dobischok, José R. Carvajal, Kyle Turner, Kaitlyn Jaffe, Eisha Lehal, Sarinn Blawatt, Casey Redquest, Rosalind Baltzer Turje, Patrick McDougall, Bryce Koch, Cheryl McDermid, Damon Hassan, Scott Harrison and Eugenia Oviedo-Joekes
    Citation: Addiction Science & Clinical Practice 2023 18:73
    Content type: Research Published on:

  17. Scaling up overdose education and naloxone distribution (OEND), an evidence-based practice for reducing opioid overdose mortality, in communities remains a challenge. Novel models and intentional implementatio...

    Authors: Hannah K. Knudsen, Patricia R. Freeman, Douglas R. Oyler, Carrie B. Oser and Sharon L. Walsh
    Citation: Addiction Science & Clinical Practice 2023 18:72
    Content type: Research Published on:

  18. The harms of opioid use disorder (OUD) and HIV infection disproportionately impact marginalized populations, especially people experiencing homelessness and people who inject drugs (PWID). Mobile OUD service d...

    Authors: Rebecca E. Stewart, Hanna P. Christian, Nicholas C. Cardamone, Catherine Abrams, Caroline Drob, David S. Mandell, David Metzger and Margaret Lowenstein
    Citation: Addiction Science & Clinical Practice 2023 18:71
    Content type: Research Published on:

  19. Preventing progression to moderate or severe opioid use disorder (OUD) among people who exhibit risky opioid use behavior that does not meet criteria for treatment with opioid agonists or antagonists (subthres...

    Authors: Jane M. Liebschutz, Geetha A. Subramaniam, Rebecca Stone, Noa Appleton, Lillian Gelberg, Travis I. Lovejoy, Amanda M. Bunting, Charles M. Cleland, Karen E. Lasser, Donna Beers, Catherine Abrams, Jennifer McCormack, Gail E. Potter, Ashley Case, Leslie Revoredo, Eve M. Jelstrom…
    Citation: Addiction Science & Clinical Practice 2023 18:70
    Content type: Study Protocol Published on:

  20. The TAPS Tool (“Tobacco, Alcohol, Prescription drug, and illicit Substance use”) is a screening and brief assessment for detecting unhealthy substance use in healthcare settings that was developed by the National...

    Authors: Jan Gryczynski, Katherine Sanchez, Steven B. Carswell and Robert P. Schwartz
    Citation: Addiction Science & Clinical Practice 2023 18:69
    Content type: Study Protocol Published on:

  21. At-risk alcohol use and tobacco smoking often co-occur. We investigated whether brief alcohol interventions (BAIs) among general hospital patients with at-risk alcohol use may also reduce tobacco smoking over ...

    Authors: Filipa Krolo-Wicovsky, Sophie Baumann, Anika Tiede, Gallus Bischof, Ulrich John, Beate Gaertner and Jennis Freyer-Adam
    Citation: Addiction Science & Clinical Practice 2023 18:68
    Content type: Research Published on:

    The Correction to this article has been published in Addiction Science & Clinical Practice 2023 18:74

  22. Acute-care interventions that identify patients with substance use disorders (SUDs), initiate treatment, and link patients to community-based services, have proliferated in recent years. Yet, much is unknown a...

    Authors: Noa Krawczyk, Bianca D. Rivera, Ji E. Chang, Margaux Grivel, Yu-Heng Chen, Suhas Nagappala, Honora Englander and Jennifer McNeely
    Citation: Addiction Science & Clinical Practice 2023 18:67
    Content type: Research Published on:

  23. Tent encampments in the neighborhood surrounding Boston Medical Center (BMC) grew to include 336 individuals at points between 2019 and 21, prompting public health concerns. BMC, the City of Boston, and Common...

    Authors: Miriam Komaromy, Andrea Stone, Alicia Peterson, Jacqueline Gott, Rob Koenig and Jessica L. Taylor
    Citation: Addiction Science & Clinical Practice 2023 18:66
    Content type: Research Published on:

  24. Approximately 50% of the patients who globally seek help in psychiatry have been assessed with problematic substance use or been diagnosed with substance use disorder (SUD). Given the high treatment gap for me...

    Authors: Elisabeth Petersén, Hanna Augustsson and Anne H. Berman
    Citation: Addiction Science & Clinical Practice 2023 18:65
    Content type: Research Published on:

  25. The Health of the Nation Outcome Scale (HoNOS) is a widely used 12-item tool to assess mental health and social functioning. The French version has an added 13th item measuring adherence to psychotropic medica...

    Authors: Anne Chatton, Yasser Khazaal and Louise Penzenstadler
    Citation: Addiction Science & Clinical Practice 2023 18:64
    Content type: Research Published on:

  26. Client discontinuation from outpatient addiction treatment programs is common, and the initial intake is the service delivery point with the highest attrition rate. Replacing the comprehensive intake assessmen...

    Authors: Margo C. Hurlocker, Theresa B. Moyers, Melissa Hatch, Geoffrey Curran, Barbara McCrady, Kamilla L. Venner and Katie Witkiewitz
    Citation: Addiction Science & Clinical Practice 2023 18:63
    Content type: Study Protocol Published on:

  27. GHB (gammahydroxybutyrate) and its precursors are popular recreational drugs due to their sedative, anxiolytic and sexually stimulating effects. Their use has been steadily increasing in recent years. The deto...

    Authors: Peter Neu, Heidi Danker-Hopfe, Robert Fisher and Felicitas Ehlen
    Citation: Addiction Science & Clinical Practice 2023 18:62
    Content type: Research Published on:

  28. During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding and promote access to treatment.

    Authors: Shannon Gwin Mitchell, Julia Jester, Jan Gryczynski, Melanie Whitter, Douglas Fuller, Caroline Halsted and Robert P. Schwartz
    Citation: Addiction Science & Clinical Practice 2023 18:61
    Content type: Research Published on:

  29. Oral antiretroviral therapy (ART) has been effective at reducing mortality rates of people with HIV. However, despite its effectiveness, people who use drugs face barriers to maintaining ART adherence. Receipt...

    Authors: Kirsten J. Langdon, Anthony E. Hitch, Alexandra B. Collins, Curt G. Beckwith, Sara Becker, Karen Tashima and Josiah D. Rich
    Citation: Addiction Science & Clinical Practice 2023 18:60
    Content type: Study Protocol Published on:

  30. The time after contact with specialized health services for mental health and substance use is associated with an increased risk of suicide, where temporal aspects of suicide and comorbid mental disorders in p...

    Authors: Martin Ø. Myhre, Fredrik A. Walby, Jørgen G. Bramness and Lars Mehlum
    Citation: Addiction Science & Clinical Practice 2023 18:59
    Content type: Research Published on:

  31. Youth, 18 to 24 years, experiencing homelessness (YEH) are recognized as having developmental challenges dissimilar to older adults. Yet, research on efforts to end homelessness and prevent or intervene in dru...

    Authors: Natasha Slesnick, Brittany Brakenhoff, Alicia Bunger, Laura Chavez, Caleb Cuthbertson, Ruri Famelia, Xin Feng, Maggie Fitzpatrick, Jodi Ford, Irene Hatsu, Eugene Holowacz, Soren Jaderlund, Kelly Kelleher, Ellison Luthy, Allen Mallory, Jared Martin…
    Citation: Addiction Science & Clinical Practice 2023 18:58
    Content type: Review Published on:

  32. Recovery from substance use is commonly seen as a process of integrating social relationships and creating a sense of meaning in one’s life. Dog owners describe a close relationship with their dog that impacts...

    Authors: Andi Kerr-Little, Jørgen G. Bramness, Ruth C. Newberry and Stian Biong
    Citation: Addiction Science & Clinical Practice 2023 18:57
    Content type: Research Published on:

  33. Screening for substance use in rural primary care clinics faces unique challenges due to limited resources, high patient volumes, and multiple demands on providers. To explore the potential for electronic heal...

    Authors: Jennifer McNeely, Bethany McLeman, Trip Gardner, Noah Nesin, Vijay Amarendran, Sarah Farkas, Aimee Wahle, Seth Pitts, Margaret Kline, Jacquie King, Carmen Rosa, Lisa Marsch, John Rotrosen and Leah Hamilton
    Citation: Addiction Science & Clinical Practice 2023 18:56
    Content type: Research Published on:

  34. Alcohol use disorder (AUD) commonly causes hospitalization, particularly for individuals disproportionately impacted by structural racism and other forms of marginalization. The optimal approach for engaging h...

    Authors: E. Jennifer Edelman, Oscar F. Rojas-Perez, Charla Nich, Joanne Corvino, Tami Frankforter, Derrick Gordon, Ayana Jordan, Manuel Paris, Jr, Melissa B. Weimer, Brian T. Yates, Emily C. Williams and Brian D. Kiluk
    Citation: Addiction Science & Clinical Practice 2023 18:55
    Content type: Study Protocol Published on:

  35. Opioid overdoses have continued to increase since the start of the COVID-19 pandemic. The pathways through which the COVID-19 pandemic has affected trajectories of opioid use and opioid-related problems are la...

    Authors: Tim Janssen, Bryan R. Garner, Julia Yermash, Kimberly R. Yap and Sara J. Becker
    Citation: Addiction Science & Clinical Practice 2023 18:54
    Content type: Research Published on:

  36. Substance use in women is associated with unique psycho-social and physical vulnerabilities and poses complex challenges during pregnancy and motherhood. Gender-sensitive drug policy which considers the needs ...

    Authors: Abhishek Ghosh, Dijana Jerkovic, Liljana Aleksandar Ignjatova, Carla Bruguera, Dalia I. Ibrahim, Katarzyna Okulicz-Kozaryn, J. Maphisa Maphisa, Thomas F. Martinelli, Ana Neto, Joana Canedo and Rebecca Gordon
    Citation: Addiction Science & Clinical Practice 2023 18:53
    Content type: Research Published on:

  37. Research suggests peer support groups can amplify and extend treatment effects and enhance long-term recovery from Alcohol and Other Drug (AOD) problems. However, they are rarely integrated into outpatient tre...

    Authors: V. Manning, A. D. Roxburgh and M. Savic
    Citation: Addiction Science & Clinical Practice 2023 18:52
    Content type: Research Published on:

  38. We use a novel, longitudinal approach to describe average time spent in opioid use disorder (OUD) cascade of care stages for people with HIV (PWH) and with OUD, incorporating four definitions of treatment rete...

    Authors: Jarratt D. Pytell, Anthony T. Fojo, Jeanne C. Keruly, LaQuita N. Snow, Oluwaseun Falade-Nwulia, Richard D. Moore, Geetanjali Chander and Catherine R. Lesko
    Citation: Addiction Science & Clinical Practice 2023 18:51
    Content type: Research Published on:

  39. In studies of the general population and of military veterans, many primary care patients with hazardous drinking and PTSD and/or depression (abbreviated here as HD +) do not initiate or engage with alcohol-re...

    Authors: Michael A. Cucciare, Kathy Marchant, Cristy Benton, Deanna Hildebrand, Sharfun Ghaus, Xiaotong Han, Ronald G. Thompson and Christine Timko
    Citation: Addiction Science & Clinical Practice 2023 18:50
    Content type: Study Protocol Published on:

  40. A valid opioid use disorder (OUD) identification algorithm for use in administrative medical record data would enhance investigators’ ability to study consequences of OUD, OUD treatment seeking and treatment o...

    Authors: Jeffrey F. Scherrer, Mark D. Sullivan, Marc R. LaRochelle and Richard Grucza
    Citation: Addiction Science & Clinical Practice 2023 18:49
    Content type: Commentary Published on:

  41. An emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related to concomitant methamphetamine/opioid use. This presents a potential ri...

    Authors: Cayley Russell, Justine Law, Sameer Imtiaz, Jürgen Rehm, Bernard Le Foll and Farihah Ali
    Citation: Addiction Science & Clinical Practice 2023 18:48
    Content type: Review Published on:

  42. We examined acceptability of and preferences for potential medications for treating methamphetamine use disorder (MUD) among people who use methamphetamine and examined how benefits and drawbacks of methamphet...

    Authors: Karla D. Wagner, Charles Marks, Phillip Fiuty, Robert W. Harding and Kimberly Page
    Citation: Addiction Science & Clinical Practice 2023 18:47
    Content type: Research Published on:

  43. A minority of all individuals with alcohol use disorders (AUD) seek treatment, where stigma is one prominent barrier. Social support is important to facilitate health and increase treatment-seeking. Whether th...

    Authors: Sara Wallhed Finn, Anna Mejldal and Anette Søgaard Nielsen
    Citation: Addiction Science & Clinical Practice 2023 18:46
    Content type: Research Published on:

  44. Pharmacy administration and dispensing of methadone treatment for opioid use disorder (PADMOUD) may address inadequate capability of opioid treatment programs (OTPs) in the US by expanding access to methadone ...

    Authors: Li-Tzy Wu, William S. John, Paolo Mannelli, Eric D. Morse, Alyssa Anderson and Robert P. Schwartz
    Citation: Addiction Science & Clinical Practice 2023 18:45
    Content type: Research Published on:

  45. Motivational enhancement therapy (MET) has shown to be efficacious as treatment of alcohol use disorder (AUD), in reducing alcohol consumption and related consequences. However, qualitative research on how pat...

    Authors: Stina Ingesson Hammarberg, Jennie Sundbye, Rebecca Tingvall, Anders Hammarberg and Christina Nehlin
    Citation: Addiction Science & Clinical Practice 2023 18:44
    Content type: Research Published on:

  46. Use of benzodiazepines (BZD) in patients receiving opioid agonist treatment (OAT) is common and associated with a variety of negative health and social outcomes. This cross-sectional study investigates the imp...

    Authors: Maximilian Meyer, Ferdinand Gygli, Jean N. Westenberg, Otto Schmid, Johannes Strasser, Undine E. Lang, Kenneth M. Dürsteler and Marc Vogel
    Citation: Addiction Science & Clinical Practice 2023 18:43
    Content type: Research Published on:

  47. Acute care inpatient admissions outside of psychiatric facilities have been increasingly identified as a critical touchpoint for opioid use disorder (OUD) treatment. We sought to describe non-opioid overdose h...

    Authors: Sudha R. Raman, Cassie B. Ford, Bradley G. Hammill, Amy G. Clark, Dana C. Clifton and George L. Jackson
    Citation: Addiction Science & Clinical Practice 2023 18:42
    Content type: Research Published on:

  48. Extant literature is limited on adoption of evidence-based harm reduction strategies in hospitals. We explored patient perceptions of incorporating harm reduction supplies and education in hospital care with p...

    Authors: Rachel French, M. Holliday Davis, Shoshana V. Aronowitz, Molly Crowe, Matthew Abrams, Grace Edwards and Margaret Lowenstein
    Citation: Addiction Science & Clinical Practice 2023 18:41
    Content type: Research Published on:

  49. Syringe services programs (SSPs) provide a spectrum of health services to people who use drugs, with many providing referral and linkage to substance use disorder (SUD) treatment, and some offering co-located ...

    Authors: Andrea Jakubowski, Sabrina Fowler and Aaron D. Fox
    Citation: Addiction Science & Clinical Practice 2023 18:40
    Content type: Research Published on:

  50. Breaking Free Online (BFO), a computer-assisted therapy (CAT) program for substance use disorders (SUD), has been available across UK treatment services for the past decade and has demonstrated efficacy. The C...

    Authors: Sarah Elison-Davies, Lauren Pittard, Tracey Myton, Andrew Jones, Jonathan Ward and Glyn Davies
    Citation: Addiction Science & Clinical Practice 2023 18:39
    Content type: Study Protocol Published on:
Submit manuscript
  • New Content Item

Follow

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.7
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 1.062
    SCImago Journal Rank (SJR): 1.307

    Speed 2023
    Submission to first editorial decision (median days): 28
    Submission to acceptance (median days): 202

    Usage 2023
    Downloads: 755,413
    Altmetric mentions: 622

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.

Addiction Science & Clinical Practice

ISSN: 1940-0640